{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:22:53Z","timestamp":1771993373277,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00105-017-4082-5","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T12:42:30Z","timestamp":1511181750000},"page":"999-1006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Acne inversa\/Hidradenitis suppurativa: Ein Update","Acne inversa\/hidradenitis suppurativa: An update"],"prefix":"10.1007","volume":"68","author":[{"given":"R.","family":"Sabat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tsaousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rossbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kurzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Fadai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schwichtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schneider-Burrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kokolakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"4082_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Del Marmol V, Mrowietz U et\u00a0al (2015) Hidradenitis suppurativa\/acne Inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 231:184\u2013190","journal-title":"Dermatology"},{"key":"4082_CR2","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A et\u00a0al (2015) Diagnostic delay in hidradenitis suppurativa is a\u00a0global problem. Br J Dermatol 173:1546\u20131549","journal-title":"Br J Dermatol"},{"key":"4082_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","volume":"73","author":"GB Jemec","year":"2015","unstructured":"Jemec GB, Kimball AB (2015) Hidradenitis suppurativa: epidemiology and scope of the problem. J\u00a0Am Acad Dermatol 73:S4\u2013S7","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-017-4079-0","author":"R Sabat","year":"2017","unstructured":"Sabat R (2017) Acne inversa\/Hidradenitis suppurativa: a\u00a0challenge for the future. Hautarzt 68. \n                        https:\/\/doi.org\/10.1007\/s00105-017-4079-0","journal-title":"Hautarzt"},{"key":"4082_CR5","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","volume":"7","author":"R Sabat","year":"2012","unstructured":"Sabat R, Chanwangpong A, Schneider-Burrus S et al (2012) Increased prevalence of metabolic syndrome in patients with acne inversa. PLOS ONE 7:e31810","journal-title":"PLOS ONE"},{"key":"4082_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","volume":"152","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Gislason GH, Hansen PR (2016) Risk of major adverse cardiovascular events and all-cause mortality in patients with Hidradenitis Suppurativa. JAMA Dermatol 152:429\u2013434","journal-title":"JAMA Dermatol"},{"key":"4082_CR7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000448838","volume":"232","author":"S Schneider-Burrus","year":"2016","unstructured":"Schneider-Burrus S, Witte-Haendel E, Christou D et al (2016) High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa. Dermatology 232:606\u2013612","journal-title":"Dermatology"},{"key":"4082_CR8","first-page":"743","volume":"11","author":"A Kurek","year":"2013","unstructured":"Kurek A, Peters JEM, Sabat R, Sterry W, Schneider-Burrus S (2013) Depression is a\u00a0frequent co-morbidity in patients with acne inversa. J\u00a0Dtsch Dermatol Ges 11:743\u2013749, 743\u2013750","journal-title":"J Dtsch Dermatol Ges"},{"key":"4082_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2015","unstructured":"Shavit E, Dreiher J, Freud T et\u00a0al (2015) Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 29:371\u2013376","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4082_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130:226\u2013238","journal-title":"Pharmacol Ther"},{"key":"4082_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"4082_CR12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1524-4733.2007.00251.x","volume":"11","author":"JM Gelfand","year":"2008","unstructured":"Gelfand JM, Kimball AB, Mostow EN et al (2008) Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment. Value Health 11:400\u2013407","journal-title":"Value Health"},{"key":"4082_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K et al (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29\u201335","journal-title":"Lancet"},{"key":"4082_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","volume":"76","author":"IE Deckers","year":"2017","unstructured":"Deckers IE, Benhadou F, Koldijk MJ et al (2017) Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a\u00a0multicenter cross-sectional study. J\u00a0Am Acad Dermatol 76:49\u201353","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"L Matusiak","year":"2010","unstructured":"Matusiak L, Bieniek A, Szepietowski JC (2010) Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 90:264\u2013268","journal-title":"Acta Derm Venereol"},{"key":"4082_CR16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein P, Loundou A, Barrau K et\u00a0al (2007) Quality of life impairment in hidradenitis suppurativa: a\u00a0study of 61 cases. J\u00a0Am Acad Dermatol 56:621\u2013623","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","volume":"67","author":"A Kurek","year":"2012","unstructured":"Kurek A, Peters EM, Chanwangpong A et\u00a0al (2012) Profound disturbances of sexual health in patients with acne inversa. J\u00a0Am Acad Dermatol 67:422\u2013428, 428 e421","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB (2014) Hidradenitis suppurativa: a\u00a0common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med\u00a0J 90:216\u2013221 (quiz 220)","journal-title":"Postgrad Med J"},{"key":"4082_CR19","first-page":"87","volume":"28","author":"NF Yasar","year":"2016","unstructured":"Yasar NF, Uylas MU, Baspinar M et\u00a0al (2016) Evaluating the use of hematological parameters in staging hidradenitis suppurativa. Wounds 28:87\u201391","journal-title":"Wounds"},{"key":"4082_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DSS.0000000000000944","volume":"43","author":"GM Makris","year":"2017","unstructured":"Makris GM, Poulakaki N, Papanota AM et\u00a0al (2017) Vulvar, perianal and perineal cancer after hidradenitis suppurativa: a systematic review and pooled analysis. Dermatol Surg 43:107\u2013115","journal-title":"Dermatol Surg"},{"key":"4082_CR21","first-page":"730","volume":"137","author":"J Lapins","year":"2001","unstructured":"Lapins J, Ye W, Nyren O, Emtestam L (2001) Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 137:730\u2013734","journal-title":"Arch Dermatol"},{"key":"4082_CR22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/iwj.12671","volume":"14","author":"N Jourabchi","year":"2017","unstructured":"Jourabchi N, Fischer AH, Cimino-Mathews A, Waters KM, Okoye GA (2017) Squamous cell carcinoma complicating a\u00a0chronic lesion of hidradenitis suppurativa: a\u00a0case report and review of the literature. Int Wound\u00a0J 14:435\u2013438","journal-title":"Int Wound J"},{"key":"4082_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1477-7819-11-313","volume":"11","author":"N Yu","year":"2013","unstructured":"Yu N, Long X, Lujan-Hernandez JR et al (2013) Marjolin\u2019s ulcer: a\u00a0preventable malignancy arising from scars. World J Surg Oncol 11:313","journal-title":"World J Surg Oncol"},{"key":"4082_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00000637-199105000-00008","volume":"26","author":"ST Williams","year":"1991","unstructured":"Williams ST, Busby RC, DeMuth RJ, Nelson H (1991) Perineal hidradenitis suppurativa: presentation of two unusual complications and a\u00a0review. Ann Plast Surg 26:456\u2013462","journal-title":"Ann Plast Surg"},{"key":"4082_CR25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA et\u00a0al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N\u00a0Engl J Med 375:422\u2013434","journal-title":"N Engl J Med"},{"key":"4082_CR26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2013.06.042","volume":"69","author":"I Cosmatos","year":"2013","unstructured":"Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P (2013) Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J\u00a0Am Acad Dermatol 69:819","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD (2013) Incidence of hidradenitis suppurativa and associated factors: a\u00a0population-based study of Olmsted County, Minnesota. J\u00a0Invest Dermatol 133:97\u2013103","journal-title":"J Invest Dermatol"},{"key":"4082_CR28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J\u00a0Am Acad Dermatol 59:596\u2013601","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","volume":"35","author":"GB Jemec","year":"1996","unstructured":"Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J\u00a0Am Acad Dermatol 35:191\u2013194","journal-title":"J Am Acad Dermatol"},{"key":"4082_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","volume":"119","author":"GB Jemec","year":"1988","unstructured":"Jemec GB (1988) The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 119:345\u2013350","journal-title":"Br J Dermatol"},{"key":"4082_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","volume":"164","author":"M Laffert von","year":"2011","unstructured":"von Laffert M, Stadie V, Wohlrab J, Marsch WC (2011) Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol 164:367\u2013371","journal-title":"Br J Dermatol"},{"key":"4082_CR32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk K, Warszawska K, Hoeflich C et al (2011) Deficiency of IL-22 contributes to a\u00a0chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J\u00a0Immunol 186:1228\u20131239","journal-title":"J Immunol"},{"key":"4082_CR33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s004030050467","volume":"291","author":"K Asadullah","year":"1999","unstructured":"Asadullah K, Sabat R, Wiese A et al (1999) Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res 291:628\u2013636","journal-title":"Arch Dermatol Res"},{"key":"4082_CR34","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200939687","volume":"39","author":"K Wolk","year":"2009","unstructured":"Wolk K, Witte E, Warszawska K et al (2009) The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a\u00a0novel immunological cascade with potential relevance in psoriasis. Eur J Immunol 39:3570\u20133581","journal-title":"Eur J Immunol"},{"key":"4082_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13:21\u201338","journal-title":"Nat Rev Drug Discov"},{"key":"4082_CR36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","volume":"94","author":"L Matusiak","year":"2014","unstructured":"Matusiak L, Bieniek A, Szepietowski JC (2014) Bacteriology of hidradenitis suppurativa\u2014which antibiotics are the treatment of choice? Acta Derm Venereol 94:699\u2013702","journal-title":"Acta Derm Venereol"},{"key":"4082_CR37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","volume":"153","author":"HC Ring","year":"2017","unstructured":"Ring HC, Thorsen J, Saunte DM et\u00a0al (2017) The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol 153:897\u2013905","journal-title":"JAMA Dermatol"},{"key":"4082_CR38","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","volume":"173","author":"G Kelly","year":"2015","unstructured":"Kelly G, Hughes R, McGarry T et\u00a0al (2015) Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol 173:1431\u20131439","journal-title":"Br J Dermatol"},{"key":"4082_CR39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","volume":"174","author":"AL Lima","year":"2016","unstructured":"Lima AL, Karl I, Giner T et\u00a0al (2016) Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol 174:514\u2013521","journal-title":"Br J Dermatol"},{"key":"4082_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15424","author":"K Wolk","year":"2017","unstructured":"Wolk K, Wenzel J, Tsaousi A et al (2017) Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa\/hidradenitis suppurativa. Br J Dermatol. \n                        https:\/\/doi.org\/10.1111\/bjd.15424","journal-title":"Br J Dermatol"},{"key":"4082_CR41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2016.1201423","volume":"12","author":"A Chiricozzi","year":"2016","unstructured":"Chiricozzi A, Raimondo A, Lembo S et al (2016) Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity. Expert Rev Clin Immunol 12:1299\u20131308","journal-title":"Expert Rev Clin Immunol"},{"key":"4082_CR42","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","volume":"34","author":"S Karbach","year":"2014","unstructured":"Karbach S, Croxford AL, Oelze M et al (2014) Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Arterioscler Thromb Vasc Biol 34:2658\u20132668","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4082_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","volume":"17","author":"K Wolk","year":"2016","unstructured":"Wolk K, Sabat R (2016) Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations. Rev Endocr Metab Disord 17:305\u2013317","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"4082_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13578-015-0060-8","volume":"15","author":"R Sabat","year":"2015","unstructured":"Sabat R, Wolk K (2015) Deciphering the role of interleukin-22 in metabolic alterations. Cell Biosci 15(5):68","journal-title":"Cell Biosci"},{"key":"4082_CR45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00105-016-3809-z","volume":"67","author":"R Sabat","year":"2016","unstructured":"Sabat R, Schon MP, Schakel K (2016) Psoriasis. Hautarzt 67:420\u2013421","journal-title":"Hautarzt"},{"key":"4082_CR46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00105-015-3616-y","volume":"66","author":"J Kirschke","year":"2015","unstructured":"Kirschke J, Hessam S, Bechara FG (2015) Hidradenitis suppurativa\/acne inversa: an update. Hautarzt 66:413\u2013422","journal-title":"Hautarzt"},{"key":"4082_CR47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","volume":"149","author":"K Sartorius","year":"2003","unstructured":"Sartorius K, Lapins J, Emtestam L, Jemec GB (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211\u2013213","journal-title":"Br J Dermatol"},{"key":"4082_CR48","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","volume":"171","author":"AB Kimball","year":"2014","unstructured":"Kimball AB, Jemec GB, Yang M et\u00a0al (2014) Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol 171:1434\u20131442","journal-title":"Br J Dermatol"},{"key":"4082_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15748","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis CC, Tzellos T, Kyrgidis A et\u00a0al (2017) Development and validation of IHS4, a\u00a0novel dynamic scoring system to assess hidradenitis suppurativa\/acne inversa severity. Br J Dermatol. \n                        https:\/\/doi.org\/10.1111\/bjd.15748","journal-title":"Br J Dermatol"},{"key":"4082_CR50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/13547500903075218","volume":"14","author":"L Matusiak","year":"2009","unstructured":"Matusiak L, Bieniek A, Szepietowski JC (2009) Soluble interleukin-2 receptor serum level is a\u00a0useful marker of hidradenitis suppurativa clinical staging. Biomarkers 14:432\u2013437","journal-title":"Biomarkers"},{"key":"4082_CR51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2340\/00015555-2061","volume":"95","author":"L Matusiak","year":"2015","unstructured":"Matusiak L, Salomon J, Nowicka-Suszko D, Bieniek A, Szepietowski JC (2015) Chitinase-3-like protein 1 (YKL-40): novel Biomarker of Hidradenitis Suppurativa disease activity? Acta Derm Venereol 95:736\u2013737","journal-title":"Acta Derm Venereol"},{"key":"4082_CR52","doi-asserted-by":"crossref","first-page":"4097574","DOI":"10.1155\/2016\/4097574","volume":"2016","author":"A Tsaousi","year":"2016","unstructured":"Tsaousi A, Witte E, Witte K et\u00a0al (2016) MMP8 is increased in lesions and blood of acne inversa patients: a potential link to skin destruction and metabolic alterations. Mediat Inflamm 2016:4097574","journal-title":"Mediat Inflamm"},{"key":"4082_CR53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","volume":"219","author":"G Gener","year":"2009","unstructured":"Gener G, Canoui-Poitrine F, Revuz JE et al (2009) Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a\u00a0series of 116 consecutive patients. Dermatology 219:148\u2013154","journal-title":"Dermatology"},{"key":"4082_CR54","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","volume":"154","author":"CO Mendonca","year":"2006","unstructured":"Mendonca CO, Griffiths CE (2006) Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 154:977\u2013978","journal-title":"Br J Dermatol"},{"key":"4082_CR55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","volume":"219","author":"HH Zee van der","year":"2009","unstructured":"van der Zee HH, Boer J, Prens EP, Jemec GB (2009) The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology 219:143\u2013147","journal-title":"Dermatology"},{"key":"4082_CR56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Kerdel F, Adams D et\u00a0al (2012) Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a\u00a0parallel randomized trial. Ann Intern Med 157:846\u2013855","journal-title":"Ann Intern Med"},{"key":"4082_CR57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00105-016-3812-4","volume":"67","author":"S Philipp","year":"2016","unstructured":"Philipp S, Kokolakis G, Sabat R (2016) Systemic treatments for psoriasis and psoriatic arthritis. Hautarzt 67:464\u2013471","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4082-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4082-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4082-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T17:42:00Z","timestamp":1511890920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4082-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4082"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4082-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}